Human Unitec International Medical Brands Completed Expansion in North America
Boston MA, May 11, 2020-Human Unitec International (OTC PINK: HMNU) (“HMNU” or “the company”) is growing internationally with MSK Kinesis supplements. HMNU has acquired the exclusive commercial rights for United States, Canada and the e-commerce markets for the natural supplement based on Astaxanthin. Astaxanthin is used for the treatment of respiratory and inflammatory problems caused
REPUBLIC OF SOUTH AFRICA MEDICAL MARIJUANA DISPENSARIES (RSAMMD) ANNOUNCES SUCCESSFUL TESTING RESULTS OF PROPRIETARY CANNABIS PLANT EXTRACTION TECHNOLOGY WITH JV PARTNER PROTEX PHARMA (TXTM)
Live Cannabis Plant Extraction into Highly Bioavailable, Non-psychoactive Cannabis Medicines Now Possible Johannesburg, South Africa–May 7th, 2020 – Republic of South Africa Medical Marijuana Dispensaries Pty Ltd. (RSAMMD) is pleased to announce the successful testing of its proprietary live cannabis plant extraction technology in conjunction with its joint venture partner, US-based Protext Pharma, Inc. (OTC
Cannabis Global Products Will be Featured on RxLeaf.com in new Marketing & White Label Agreement
LOS ANGELES, CA — May 07, 2020 — Cannabis Global, Inc. (OTC PINK: MCTC) (“Cannabis Global” or the “Company”), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, is proud to announce a new marketing and informational agreement with the medical cannabis online media company: RXLeaf.com. Under the terms of the agreement,
Immune Therapeutics, Inc. Focusing to Drive Shareholder Value
Winter Park, FL, May 6, 2020 —Immune Therapeutics, Inc. (OTC PINK: IMUN) (“Immune” “IMUN” or the “Company”) is a late-stage biopharmaceutical company focused on the development of T-cell activation immunotherapy to treat life-threatening or chronic diseases announced it has initiated a corporate plan to drive shareholder value. Recent economic events require that Immune revisit its
REPUBLIC OF SOUTH AFRICA MEDICAL MARIJUANA DISPENSARIES (RSAMMD) SIGNS LETTER OF INTENT WITH USA-BASED PROTEXT PHARMA (TXTM) FOR COMMERCIALIZTION OF NEXT GENERATION LIVE CANNABIS AND HEMP EXTRACTION TECHNOLOGY
Johannesburg, South Africa, April 30th, 2020 – Republic of South Africa Medical Marijuana Dispensaries Pty Ltd. (RSAMMD) is pleased to announce it has executed a letter of intent with USA-based Protext Pharma, Inc (OTC PINK: TXTM)., a biotech company engaged in the development of pharmaceutical botanical medicines that are formulated from highly-bioavailable plant extracts. Under
Success Entertainment Group International Joins Fight against the Covid 19 Pandemic
Ossian, Indiana-(Newsfile Corp. – April 28, 2020) – Success Entertainment Group International, Inc. (OTCQB: SEGN), recently acquired Renavotio Infratech, Inc. (RII) has entered the fight against the Covid 19, Pandemic by expanding into medical infrastructure space, specializing in Personal Protective Equipment, (“PPE”). RII has received orders for PPE gowns that initially will total over 80,000
SinglePoint enters JV agreement to further expand and accelerate opportunities due to increased new client (Retail and B2B) demand in Hand Sanitizer market with Simplex + Virus Killer
Worldwide Hand Sanitizer Market to cross USD 3.6 Bn by 2026 Phoenix, Arizona, April 28, 2020 – SinglePoint Inc. (OTCQB: SING) ramping up effort to meet in bound demand for hand sanitizer and other sanitizing products. The company recently entered into an LOI that quickly progressed to a JV Agreement with Box-Bioscience. The agreement will
SinglePoint Launches New Corporate Website and Corporate Video – Provides Update on Klen Hands Hand Sanitizer initial orders
Phoenix, Arizona – SinglePoint Inc. (OTCQB: SING) launches new corporate website highlighting and featuring the company’s core business entities including an updated corporate video. https://www.singlepoint.com/investing/ – The video provides an overview and outlook for 2020. Successful Pre-launch generating orders of Klen Hand Sanitizer with Moisturizing Hemp Seed Oil Klen Hands: Home Page. In the first
Contact Us
- 707-OTC-WIRE (707-682-9473)
- cs@otcprwire.com
Recent Comments